Testosterone and "Age-Related Hypogonadism"--FDA Concerns.
From the Food and Drug Administration, Silver Spring, MD.
Christine P
CP
Nguyen
Mark S
MS
Hirsch
David
D
Moeny
Suresh
S
Kaul
Mohamed
M
Mohamoud
Hylton V
HV
Joffe
D000329:Advertising; D000367:Age Factors; D000368:Aged; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D004345:Drug Industry; D004348:Drug Labeling / Q000331:legislation & jurisprudence; D033161:Government Regulation; D006801:Humans; D007006:Hypogonadism / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D015969:National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division; D056687:Off-Label Use; D013739:Testosterone / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D013739:Testosterone